secwatch.observer — SEC 8-K summary
======================================

Issuer:     ULTRALIFE CORP (ULBI)
CIK:        0000875657
Form:       8-K/A
Filed at:   2022-02-28T23:59:59+00:00
Accession:  0001437749-22-004686
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ultralife files audited Excell financials: $18.5M sales, $1.5M net income for Feb-Dec 2021 stub
--------------------------------------------------------------------------------

- Sales $18.46M, gross profit $4.32M (23.4% margin), net income $1.49M for period Feb 1-Dec 12, 2021.
- Total assets $9.0M, equity $6.45M; cash $736K, accounts receivable $3.57M, inventory $3.44M.
- Auditor MNP LLP issued qualified opinion unable to audit opening inventory affecting cost of sales.
- Company paid $4.78M dividends and repaid $729K shareholder advances during stub period.
- Acquisition closed Dec 13, 2021; financials now filed via Form 8-K/A.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875657/000143774922004686/0001437749-22-004686-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875657/000143774922004686/ulbi20220228_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-004686

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer